Production (Stage)
Lipocine Inc.
LPCN
$3.17
$0.0481.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -97.31% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -97.31% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -97.31% | -- | |||
| SG&A Expenses | 28.56% | -16.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.24% | -26.03% | |||
| Operating Income | -235.24% | 158.75% | |||
| Income Before Tax | -204.63% | 180.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -204.64% | 180.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -204.64% | 180.32% | |||
| EBIT | -235.24% | 158.75% | |||
| EBITDA | -232.89% | 159.54% | |||
| EPS Basic | -204.65% | 180.31% | |||
| Normalized Basic EPS | -204.61% | 180.33% | |||
| EPS Diluted | -211.82% | 171.02% | |||
| Normalized Diluted EPS | -211.17% | 175.59% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | -5.88% | 6.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||